These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 8244284

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Nuclear matrix protein expressions in hepatocytes of normal and cirrhotic rat livers under normal and regenerating conditions.
    Yun JP, Liew CT, Chew EC, Yin XY, Lai PB, Fai YH, Li HK, Jin ML, Ding MX, Li MT, Lin HL, Lau WY.
    J Cell Biochem; 2004 Apr 15; 91(6):1269-79. PubMed ID: 15048880
    [Abstract] [Full Text] [Related]

  • 23. Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid.
    Reif S, Aeed H, Shilo Y, Reich R, Kloog Y, Kweon YO, Bruck R.
    J Hepatol; 2004 Aug 15; 41(2):235-41. PubMed ID: 15288472
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Zonal differences in lipoprotein formation in the thioacetamide-induced micronodular-cirrhotic rat liver.
    Franke H, Potratz I, Dargel R.
    Exp Toxicol Pathol; 1994 Dec 15; 46(6):503-11. PubMed ID: 7703683
    [Abstract] [Full Text] [Related]

  • 26. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M, Ginés P, Martin PY, Tsai P, Morris K, McMurtry I, Schrier RW.
    Hepatology; 1996 Oct 15; 24(4):947-51. PubMed ID: 8855203
    [Abstract] [Full Text] [Related]

  • 27. [Dynamics of glycogen content in the normal and cirrhotic liver following glucose administration to starving rats].
    Bezborodkina NN, Kudriavtseva MV, Okovityĭ SV, Nilova VK, Kudriavtsev BN.
    Tsitologiia; 2003 Oct 15; 45(10):1019-26. PubMed ID: 14989174
    [Abstract] [Full Text] [Related]

  • 28. Arterialization of the portal vein improves hepatic microcirculation and tissue oxygenation in experimental cirrhosis.
    Yang W, Koti R, Glantzounis G, Davidson BR, Seifalian AM.
    Br J Surg; 2003 Oct 15; 90(10):1232-9. PubMed ID: 14515292
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Population of hepatic macrophages and response of perfused liver to platelet-activating factor during production of thioacetamide-induced cirrhosis in rats.
    Noda S, Masumi S, Moriyama M, Kannan Y, Ohta M, Sugano T, Yamate J.
    Hepatology; 1996 Aug 15; 24(2):412-8. PubMed ID: 8690413
    [Abstract] [Full Text] [Related]

  • 31. Insulin resistance and delayed clearance of peptide hormones in cirrhotic rat liver.
    Shankar TP, Drake S, Solomon SS.
    Am J Physiol; 1987 Jun 15; 252(6 Pt 1):E772-7. PubMed ID: 3296781
    [Abstract] [Full Text] [Related]

  • 32. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis.
    Mizumoto M, Arii S, Furutani M, Nakamura T, Ishigami S, Monden K, Ishiguro S, Fujita S, Imamura M.
    J Surg Res; 1997 Jul 01; 70(2):124-33. PubMed ID: 9245560
    [Abstract] [Full Text] [Related]

  • 33. [In vitro contractility behavior of portal veins in normal rats and in rats with liver cirrhosis--effect of calcium antagonists and octreotide].
    Hanisch E, Strasse R, Wenzel M, Lorey T.
    Z Gastroenterol; 1993 Oct 01; 31(10):600-4. PubMed ID: 8256474
    [Abstract] [Full Text] [Related]

  • 34. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
    Le Couteur DG, Hickey H, Harvey PJ, Gready J, McLean AJ.
    J Pharmacol Exp Ther; 1999 Jun 01; 289(3):1553-8. PubMed ID: 10336552
    [Abstract] [Full Text] [Related]

  • 35. In vitro and in vivo vascular responses to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis.
    Moreau R, Oberti F, Lahaye P, Gadano A, Cailmail S, Sogni P, Cales P, Lebrec D.
    J Gastroenterol Hepatol; 1998 Dec 01; 13(12):1254-8. PubMed ID: 9918435
    [Abstract] [Full Text] [Related]

  • 36. Portal vein hypoglycemia is essential for full induction of hypoglycemia-associated autonomic failure with slow-onset hypoglycemia.
    Matveyenko AV, Bohland M, Saberi M, Donovan CM.
    Am J Physiol Endocrinol Metab; 2007 Sep 01; 293(3):E857-64. PubMed ID: 17638706
    [Abstract] [Full Text] [Related]

  • 37. Splenic Doppler impedance indices: influence of different portal hemodynamic conditions.
    Bolognesi M, Sacerdoti D, Merkel C, Gerunda G, Maffei-Faccioli A, Angeli P, Jemmolo RM, Bombonato G, Gatta A.
    Hepatology; 1996 May 01; 23(5):1035-40. PubMed ID: 8621130
    [Abstract] [Full Text] [Related]

  • 38. Mucosal blood flow and modified vascular responses to norepinephrine in the stomach of rats with liver cirrhosis.
    Kitano S, Koyanagi N, Sugimachi K, Kobayashi M, Inokuchi K.
    Eur Surg Res; 1982 May 01; 14(3):221-30. PubMed ID: 7117327
    [Abstract] [Full Text] [Related]

  • 39. Bacterial translocation in thioacetamide induced liver cirrhosis in rats.
    al-Bader AA, Mathew TC, Abul H, al-Mosawi M, Panigrahi D, Dashti H.
    J R Coll Surg Edinb; 1998 Aug 01; 43(4):278-82. PubMed ID: 9735658
    [Abstract] [Full Text] [Related]

  • 40. Enhanced vasoconstrictor response of the isolated perfused cirrhotic rat liver to humoral vasoconstrictor substances found in portal venous blood.
    Grossman HJ, Grossman VL, Bhathal PS.
    J Gastroenterol Hepatol; 1992 Aug 01; 7(3):283-7. PubMed ID: 1611016
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.